| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 18.406 | 20.193 | - | 64.279 | - | 35.919 | 158.844 | 162.814 | 288.219 | 393.367 |
| Total Income - EUR | 18.406 | 20.204 | - | 64.310 | - | 36.019 | 158.886 | 163.288 | 293.741 | 399.381 |
| Total Expenses - EUR | 15.736 | 20.823 | - | 47.043 | - | 6.968 | 31.227 | 121.783 | 160.373 | 230.903 |
| Gross Profit/Loss - EUR | 2.670 | -619 | - | 17.267 | - | 29.051 | 127.659 | 41.505 | 133.368 | 168.478 |
| Net Profit/Loss - EUR | 2.117 | -1.225 | - | 15.337 | - | 27.960 | 123.039 | 37.596 | 131.013 | 158.446 |
| Employees | 0 | 0 | - | 0 | - | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - High Life Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | - | 0 | - | 0 | 28.941 | 21.289 | 60.355 | 120.008 |
| Current Assets | 4.411 | 4.673 | - | 19.714 | - | 51.045 | 162.242 | 130.996 | 174.690 | 249.847 |
| Inventories | 0 | 440 | - | 864 | - | 1.055 | 1.504 | 1.484 | 0 | 0 |
| Receivables | 1.715 | 1.742 | - | 994 | - | 20.276 | 51.006 | 28.892 | 55.310 | 50.144 |
| Cash | 2.696 | 2.491 | - | 17.857 | - | 29.714 | 109.733 | 100.619 | 48.622 | 13.455 |
| Shareholders Funds | 2.162 | 915 | - | 18.960 | - | 44.430 | 166.484 | 75.783 | 197.524 | 354.867 |
| Social Capital | 45 | 45 | - | 43 | - | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.248 | 3.758 | - | 754 | - | 6.614 | 24.699 | 76.502 | 37.593 | 15.058 |
| Income in Advance | 0 | 0 | - | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8230 - 8230" | |||||||||
| CAEN Financial Year |
8230
|
|||||||||
Comments - High Life Med Srl